While vaccine makers have voiced broad commitment to cooperating to boost production, industry representatives have insisted that intellectual property waivers and forced technology sharing was the wrong way to go.
"Our vaccine therefore costs about the same as a flu shot" Moderna's Chief Executive Stephane Bancel said to German weekly Welt am Sonntag.
"Positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent Covid-19 disease, including severe disease," says Stephane Bancel, Moderna's CEO.
Subscribe to our Youtube channel for all latest in-depth, on the ground reporting from around the world.
Copyright © 2023 TRT World.